DAYANG BIOTECH released its performance for the first three quarters, with a net profit attributable to the parent company of 80.366 million yuan, an increase of 56.12%Zhitong·Oct 20, 2025 at 03:57 AM003017+2.97%
DAYANG BIOTECH issued a preliminary increase, expecting the net profit attributable to the parent company for the first three quarters to be between 74 million yuan and 90 million yuan, a year-on-year increase of 44.35% to 75.56%Zhitong·Oct 14, 2025 at 04:18 AM003017+2.97%
The A-share chemical and chemical engineering sector fluctuated and strengthened, JJKJ hit the daily limit, DAYANG BIOTECH rose over 5%, JSAC, LIER CHEMICAL, and Yangnong Chemical followed suitZhitong·Sep 7, 2025 at 09:03 PM600486-4.65%600586+1.19%
DAYANG BIOTECH: In the first half of the year, the net profit attributable to the parent company was 50.5056 million yuan, a year-on-year increase of 60.66%Zhitong·Aug 25, 2025 at 09:08 AM003017+2.97%
DAYANG BIOTECH: The Zhejiang Regulatory Bureau has taken corrective measures against the company's shareholder Yang Xingli and his concerted actorsZhitong·Aug 6, 2025 at 06:44 AM003017+2.97%
The research enthusiasm for star companies is high, and leading enterprises frequently release positive signalsWallstreetcn·Aug 1, 2025 at 06:31 PM300149+3.14%003017+2.97%
Institutions predict that the annual performance of 7 PEEK material concept stocks is expected to growZhitong·Jul 27, 2025 at 11:41 PM301000+6.39%003017+2.97%
DAYANG BIOTECH: The market demand for Amipriline Hydrochloride is gradually increasingZhitong·Jun 26, 2025 at 04:01 AM003017+2.97%
DAYANG BIOTECH plans to grant no more than 994,100 restricted sharesZhitong·Jun 6, 2025 at 06:58 AM003017+2.97%
PEEK material concept performs outstandingly, with stocks like SELON hitting the limit upZhitong·Apr 28, 2025 at 08:55 PM002915+3.20%003017+2.97%
DAYANG BIOTECH released its 2024 annual performance, with a net profit attributable to the parent company of 63.7463 million yuan, a year-on-year increase of 27.48%Zhitong·Apr 21, 2025 at 09:01 AM003017+2.97%
DAYANG BIOTECH released its first-quarter performance, with a net profit attributable to the parent company of 29.3432 million yuan, a year-on-year increase of 73.44%Zhitong·Apr 21, 2025 at 08:57 AM003017+2.97%
DAYANG BIOTECH: Shareholders increased their holdings to 5.65%, violating relevant regulations, and the Zhejiang Regulatory Bureau issued a warning letter to themZhitong·Mar 19, 2025 at 03:15 AM003017+2.97%
U.S. Stock IPO Preview | With only 23 employees and poor fundamentals, how will commodity trading firm Tongying Group write its IPO story?Zhitong·Feb 27, 2025 at 04:49 AM003017+2.97%000060+2.41%
DAYANG BIOTECH received an increase of 800,000 shares from shareholder Yang XingliZhitong·Feb 20, 2025 at 05:02 AM003017+2.97%
